# DFWIT AI & Startup Competition 2026

# Checkpoint 2 Primary Submission

## Project Title

**OncoReconcile AI**

### AI-Powered Precision Oncology Data Quality, Governance & Interoperability Platform

**Team:** Variant Vanguard

**Repository**

https://github.com/oncoreconcile-ai/oncoreconcile-ai/tree/startup-platform

---

# Executive Summary

OncoReconcile AI is an AI-powered biomedical data quality and governance platform designed to improve the consistency, interoperability, and AI-readiness of oncology and clinical genomics data.

The platform reconciles heterogeneous disease names, genes, and genomic variants into standardized canonical representations using:

* AI-assisted entity resolution
* Evidence retrieval
* Confidence scoring
* Explainable recommendations
* Human governance workflows
* Standards-aligned exports

Rather than forcing uncertain mappings, the platform surfaces supporting evidence and routes ambiguous cases through expert review.

The result is trustworthy, explainable, and reusable oncology data suitable for precision medicine, clinical research, healthcare analytics, and future AI applications.

---

# Problem Statement

Precision oncology data is fragmented across:

* Electronic Health Records
* Molecular Diagnostics
* Clinical Trials
* Research Databases
* Claims Systems
* Real-World Evidence Platforms

The same biological concept frequently appears under different names:

| Input   | Canonical                     |
| ------- | ----------------------------- |
| HER2    | ERBB2                         |
| HER1    | EGFR                          |
| p53     | TP53                          |
| NSCLC   | Lung Non-Small Cell Carcinoma |
| Ex19del | EGFR Exon 19 Deletion         |

These inconsistencies create significant challenges for:

* Biomarker analytics
* Cohort generation
* Clinical trial matching
* Data integration
* AI model development
* Healthcare interoperability

Organizations often spend substantial effort manually harmonizing data before it becomes useful.

---

# Why This Matters

Healthcare organizations are rapidly adopting AI.

However:

**Trustworthy AI requires trustworthy data.**

Poorly standardized oncology data leads to:

* Reduced data quality
* Increased manual effort
* Inconsistent analytics
* Lower interoperability
* Reduced confidence in AI systems

OncoReconcile AI focuses on improving data quality before downstream analytics and AI workflows.

---

# Solution Overview

Input Disease / Gene / Variant

↓

Entity Resolution

↓

Evidence Retrieval

↓

Confidence Scoring

↓

Governance Decision

* AUTO_RECONCILE
* REVIEW_REQUIRED
* CANNOT_RECONCILE

↓

Human Review Workflow

↓

Curated Output

↓

FHIR / OMOP / Analytics / Knowledge Graphs

---

# Platform Capabilities

## Reconciliation

* Disease reconciliation
* Gene reconciliation
* Variant reconciliation
* Alias normalization
* Fuzzy matching
* Compound disease-gene-variant reasoning

## Evidence Intelligence

* MyVariant.info
* ClinVar
* CIViC
* ClinGen Allele Registry
* Local oncology catalogs

## Explainable AI

* Confidence scores
* Audit trails
* Alternative candidates
* Evidence packages
* Provenance tracking

## Human Governance

* Review queue
* Adjudication workflows
* Review reopening
* Governance metrics

## Interoperability

* FHIR export
* OMOP export
* Knowledge graph export
* VRS-inspired exports
* Cat-VRS-inspired exports
* VA-Spec-inspired provenance

## Analytics

* Evaluation Dashboard
* Benchmark reporting
* Reviewer metrics
* Governance metrics

---

# Technical Architecture

Raw Oncology Data

↓

Normalization Layer

↓

Disease Resolution

Gene Resolution

Variant Resolution

↓

Evidence Retrieval

↓

Confidence Scoring

↓

Governance Engine

↓

Human Review

↓

FHIR / OMOP Export

↓

Analytics & AI Applications

---

# Validation & Quality

Current platform status:

| Metric               | Result      |
| -------------------- | ----------- |
| Automated Tests      | 151 Passing |
| Frontend Build       | Passing     |
| Benchmark Framework  | Operational |
| Review Queue         | Operational |
| Evaluation Dashboard | Operational |
| Evidence Package     | Operational |
| FHIR Export          | Operational |
| OMOP Export          | Operational |

---

# Benchmark Framework

Current benchmark framework includes:

* 500 evaluation cases
* Alias normalization
* Ambiguous terminology
* Review-required scenarios
* Negative control safety testing

Representative benchmark results:

* Disease Accuracy: 68.6%
* Gene Accuracy: 96.6%
* Variant Accuracy: 94.6%
* Safety-Aware Status Accuracy: 89.8%
* Negative Control Safety Rate: 100%
* False Auto-Accept Rate: 0%

The benchmark intentionally includes difficult ambiguity scenarios to evaluate governance and safety behavior.

---

# Innovation

Key innovations include:

## Human-Governed AI

Uncertain cases are escalated to experts instead of being automatically accepted.

## Explainable Reconciliation

Every decision includes:

* Evidence
* Confidence score
* Audit trail
* Provenance

## Governance-First Design

Transparency and trust are prioritized over blind automation.

## Biomedical Focus

Purpose-built for oncology and clinical genomics workflows.

---

# Business Opportunity

Potential customers include:

* Cancer Centers
* Molecular Diagnostic Laboratories
* Pharmaceutical Companies
* Clinical Research Organizations
* Healthcare AI Companies
* Healthcare Data Platforms

Potential future offerings:

* SaaS subscriptions
* Enterprise deployments
* Reconciliation APIs
* Governance APIs
* FHIR Quality APIs
* Knowledge Graph Services

---

# Social Impact

Higher-quality oncology data can support:

* Better clinical research
* Safer healthcare AI
* Improved biomarker analytics
* Faster patient cohort discovery
* Greater interoperability

The platform promotes trustworthy AI by ensuring uncertain recommendations receive human review.

---

# Demonstration Assets

Checkpoint 2 Demo Includes:

* Single Record Reconciliation
* Human Review Queue
* Evaluation Dashboard
* Evidence Package Generation
* FHIR Export
* OMOP Export

(Add screenshots before final submission.)

---

# Long-Term Vision

OncoReconcile AI aims to become the biomedical data quality and interoperability layer for precision oncology.

Future directions include:

* Multi-cancer support
* Enterprise APIs
* Biomedical Knowledge Graphs
* AI-Assisted Curation
* Clinical Trial Harmonization
* Precision Oncology Intelligence Platforms

---

# Repository

Primary Submission Branch:

**startup-platform**

https://github.com/oncoreconcile-ai/oncoreconcile-ai/tree/startup-platform

---

# Disclaimer

OncoReconcile AI is a biomedical data harmonization and governance platform.

It is not a clinical decision support system and does not provide diagnosis, treatment recommendations, or medical advice.
